Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. Februar 2025 09:00 ET | Quelle: Pardeep Nijhawan

Information Provided Pursuant to Early Warning Requirements with Respect to Par Nijhawan and Velan Capital

MARKHAN, Ontario, Feb. 13, 2025 (GLOBE NEWSWIRE) -- February 13, 2025 - Dr. Pardeep Nijhawan (“Dr. Nijhawan”) and Velan Capital jointly announce updates to their beneficial ownership of securities...
13. September 2024 19:38 ET | Quelle: Pardeep Nijhawan

Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

MARKHAM, Ontario, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Dr. Pardeep Nijhawan (“Dr. Nijhawan”) announces that as a result of grants of restricted share units (“RSUs”) of Edesa Biotech, Inc. (“Edesa”),...
17. November 2022 19:26 ET | Quelle: Pardeep Nijhawan

Pardeep Nijhawan Acquires Beneficial Ownership of Additional Securities of Edesa Biotech, Inc.

MARKHAM, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Dr. Pardeep Nijhawan (“Dr. Nijhawan”) announces that his beneficial ownership of common shares (“Common Shares”) in the capital of Edesa Biotech,...